Editors' ChoiceImmunotherapy

Combination of an oncolytic virus with PD-L1 blockade keeps cancer in check

See allHide authors and affiliations

Science Translational Medicine  19 Apr 2017:
Vol. 9, Issue 386, eaan2781
DOI: 10.1126/scitranslmed.aan2781


An oncolytic vaccinia virus expressing CXCL11 combined with PD-L1 blockade significantly reduces tumor burden and improves survival in murine cancer models.

View Full Text

Stay Connected to Science Translational Medicine